The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase β
Open Access
- 1 April 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (17) , 13017-13025
- https://doi.org/10.1074/jbc.275.17.13017
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase βOncogene, 1999
- NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug CisplatinBiochemistry, 1998
- Increased Activity and Fidelity of DNA Polymerase β on Single-nucleotide Gapped DNAJournal of Biological Chemistry, 1997
- Bypass Replication of the Cisplatin-d(GpG) Lesion by Calf Thymus DNA Polymerase β and Human Immunodeficiency Virus Type I Reverse Transcriptase Is Highly MutagenicPublished by Elsevier ,1996
- Roadblocks and detours during DNA replication: Mechanisms of mutagenesis in mammalian cellsBioEssays, 1994
- Effects of the anticancer drug cis-diamminedichloroplatinum(II) on the activities of calf thymus DNA polymerase .epsilon.Biochemistry, 1993
- Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cellsCarcinogenesis: Integrative Cancer Research, 1991
- Spectrum ofcis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cellsMolecular Carcinogenesis, 1991
- Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracilEuropean Journal of Cancer and Clinical Oncology, 1990
- Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell lineCancer Letters, 1988